ProfileGDS4132 / 236160_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 35% 43% 42% 40% 35% 29% 38% 43% 45% 44% 51% 48% 61% 46% 55% 50% 35% 39% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10193.127736
GSM201543Muscle PCOS pioglitazone 12181.11735
GSM201544Muscle PCOS pioglitazone 161114.49343
GSM201545Muscle PCOS pioglitazone 201116.11742
GSM201829Muscle PCOS pioglitazone 231109.85840
GSM201830Muscle PCOS pioglitazon 25193.409335
GSM201831Muscle PCOS pioglitazone 27168.764929
GSM201832Muscle PCOS pioglitazone 3196.615438
GSM201833Muscle PCOS pioglitazone 41105.45143
GSM201834Muscle PCOS pioglitazone 81115.30545
GSM201835Muscle PCOS after pioglitazone 102102.16644
GSM201836Muscle PCOS after pioglitazone 122126.80951
GSM201837Muscle PCOS after pioglitazone 162109.40248
GSM201838Muscle PCOS after pioglitazone 202162.31261
GSM201839Muscle PCOS after pioglitazone 232112.06146
GSM201840Muscle PCOS after pioglitazone 252148.21455
GSM201841Muscle PCOS after pioglitazone 272117.51850
GSM201842Muscle PCOS after pioglitazone 3271.615335
GSM201843Muscle PCOS after pioglitazone 4297.979639
GSM201844Muscle PCOS after pioglitazone 82123.91848